New Alzheimer’s drug repairs DNA damage and reduces brain inflammation
Researchers at King’s College London have identified a promising new strategy for tackling Alzheimer’s disease by targeting several of the disease’s earliest biological changes at the same time. Their study found that KCL-286, an experimental drug originally developed for spinal cord injury that…